MKI67 and breast cancer: For example, digital estimations of the Her2μ, Ki67 and Pan Cytokeratin [AE1/AE3] have shown relatively better assessment of the marker expressions in breast cancer [38], neuroendocrine tumor [39] and colorectal cancers [40], respectively.